Joanna Plisiecka-Hałasa

Author

The Maria Sklodowska-Curie National Research Institute of Oncology

Also Known As

Agnieszka Dansonka-Mieszkowska, Agnieszka Podgorska, J Plisiecka-Hałasa, J. PLISIECKA‐HAŁASA, J. Plisiecka-Halasa, J. Plisiecka-Hałasa, Joanna Plisiecka-Halasa, Joanna Plisiecka-Hałasa, Joanna Plisiecka‐Halasa, Julie M. Cunningham

Publications

608

Citations

H-Index

Concepts

All Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology Pomeranian Medical University Poznan University of Medical Sciences Harvard University BC Cancer Agency

About

Joanna Plisiecka-Hałasa is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in pathology, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	214
2	Pathology	4	4	214
3	Obstetrics	3	3	161
4	Cell Biology	2	2	168
5	Cancer Cell Biology	2	2	139

Joanna Plisiecka-Hałasa

Publications

336

Citations

H-Index

Page 1

	Year	Citations
Ovarian small cell carcinoma of hypercalcemic type – evidence of germline origin and smarca4 gene inactivation. a pilot study Jolanta Kupryjańczyk, Agnieszka Dansonka‐Mieszkowska, Joanna Moes-Sosnowska, Polish Journal of Pathology Immature TeratomaSmarca4 Gene InactivationPathologyGynecologyTumor Biology	2013	115
P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens Joanna Plisiecka-Hałasa, G Karpińska, T Szymańska, Annals of Oncology Platinum-based RegimensOvarian CarcinomasMedicinePathologyCancer Genomics	2003	53
TP53 status determines clinical significance of ERBB2 expression in ovarian cancer Jolanta Kupryjańczyk, Radosław Mądry, Joanna Plisiecka-Hałasa, British Journal of Cancer	2004	38
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type Joanna Moes-Sosnowska, Lukasz M. Szafron, Dorota Nowakowska, Orphanet Journal of Rare Diseases	2015	34
Nijmegen breakage syndrome gene (<i>NBS1</i>) alterations and its protein (nibrin) expression in human ovarian tumours Joanna Plisiecka-Hałasa, Agnieszka Dansonka‐Mieszkowska, Alina Rembiszewska, Annals of Human Genetics Tumoral PathologyNibrin ExpressionNbs1 Gene AlterationsGeneticsMedicine	2002	24
High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations Iwona K. Rzepecka, Lukasz M. Szafron, Agnieszka Styś, Cancer Genetics Allelic LossOncologyBrca1 LocusMedicineGynecology	2012	22
Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study Alice W. Lee, Jonathan P. Tyrer, Jennifer A. Doherty, Gynecologic Oncology	2014	19
Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas. Joanna Plisiecka-Hałasa, Agnieszka Dansonka‐Mieszkowska, Ewa Kraszewska, PubMed	2008	19
Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk Linda E. Kelemen, Kathryn L. Terry, Marc T. Goodman, Molecular Nutrition & Food Research	2014	12

Page 1